subject: Global Generics ----aarkstore Enterprise [print this page] Global generics market was valued at US$106.12 billion in 2008, registering a growth of 12.56% over the previous year, which is five times that of patented drugs. Cygnus estimates that the global generics market will sustain a CAGR of 14% during the period, 2008-12. Patent expiries of blockbuster drugs and increasing healthcare expenditure will continue to drive the growth of the industry. The major generic firms will become more dominant with further acquisitions in future.
Scope of the Report:
i. Global generics market overview with various patent challenges, mergers and acquisitions and regional market overview (North America, Europe and Asia Pacific) along with growth drivers of the industry are discussed to provide a broad global scenario of the market.
ii. The industry faces several challenges, which are discussed in Issues and Challenges chapter.
iii. The R&D expenditure of global generics companies has been discussed separately, followed by regulations of the industry.
iv. Ten leading industry players are discussed in Major Players chapter discussing their Business Profile, Financial Profile, Key Strategies, Outlook followed by critical success factors.
v. Another important topic i.e. key patent expiries during 2008-12 has been discussed along with the future outlook of the industry.
Reasons to Buy
Provides insight into the key concepts of Global Generics in a comprehensive manner
Useful to pharma industry experts, global investors and generics companies.
Prepares students of Pharma Courses to face the industry confidently
Can assess the industry status broadly by Financial institutes, offering term loans to generic pharma companies
